James M. Daly

Exec. VP & Chief Comm. Officer, Incyte.

Companies

CytokineticsBoard member Aug 20, 2025 to now¹
MADRIGAL PHARMACEUTICALS, INC.Board member Jul 1, 2019 to now²
Acadia PharmaceuticalsBoard member Jan 11, 2016 to now³
Halozyme TherapeuticsBoard member Mar 8, 2016 to Aug 15, 2023⁴
BELLICUM PHARMACEUTICALS, INCBoard member May 19, 2016 to Jan 5, 2023⁵
Chimerix (United States)Board member Jun 23, 2014 to Jun 24, 2019⁶
IncyteExec. VP & Chief Comm. Officer Oct 23, 2012 to Jun 25, 2015⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Halozyme Therapeutics HALO20,503 shares⁸$2.5M at $121.51Aug 14, 2023
MADRIGAL PHARMACEUTICALS, INC. MDGL3,081 shares⁹$1.4M at $459.81Jun 17, 2026
Acadia Pharmaceuticals ACAD12,148 shares¹⁰$232.3K at $19.12May 29, 2026
Cytokinetics CYTK3,390 shares¹¹$210.0K at $61.95Jul 15, 2026
BELLICUM PHARMACEUTICALS, INC109,873 shares¹²Jan 3, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 15, 2026Granted 151 shares at $82.62 of Cytokinetics¹¹
Jun 17, 2026Granted 454 shares of MADRIGAL PHARMACEUTICALS, INC.⁹
May 29, 2026Exercised options 8,107 shares of Acadia Pharmaceuticals¹⁰
May 27, 2026Granted 2,851 shares of Cytokinetics¹³
Apr 15, 2026Granted 191 shares at $65.37 of Cytokinetics¹⁴
Jan 15, 2026Granted 197 shares at $63.44 of Cytokinetics¹⁵
Nov 10, 2025Sold 30,000 shares at $22.37 of Acadia Pharmaceuticals¹⁶
Jun 20, 2025Granted 715 shares of MADRIGAL PHARMACEUTICALS, INC.¹⁷
May 29, 2025Exercised options 9,387 shares of Acadia Pharmaceuticals¹⁸
Feb 27, 2025Sold 770 shares at $348.94 of MADRIGAL PHARMACEUTICALS, INC.¹⁹
Feb 27, 2025Sold 14,302 shares at $347.39 of MADRIGAL PHARMACEUTICALS, INC.¹⁹
Feb 27, 2025Sold 398 shares at $346.90 of MADRIGAL PHARMACEUTICALS, INC.¹⁹
Feb 27, 2025Exercised options 6,000 shares at $111.06 of MADRIGAL PHARMACEUTICALS, INC.¹⁹
Feb 27, 2025Exercised options 9,470 shares at $65.06 of MADRIGAL PHARMACEUTICALS, INC.¹⁹
Jun 25, 2024Granted 714 shares of MADRIGAL PHARMACEUTICALS, INC.²⁰
May 29, 2024Exercised options 6,652 shares of Acadia Pharmaceuticals²¹
Apr 2, 2024Sold 200 shares at $248.45 of MADRIGAL PHARMACEUTICALS, INC.²²
Apr 2, 2024Sold 43 shares at $247.03 of MADRIGAL PHARMACEUTICALS, INC.²²
Apr 2, 2024Sold 557 shares at $246.30 of MADRIGAL PHARMACEUTICALS, INC.²²
Apr 2, 2024Sold 2,991 shares at $244.89 of MADRIGAL PHARMACEUTICALS, INC.²²
Apr 2, 2024Sold 6,279 shares at $244.19 of MADRIGAL PHARMACEUTICALS, INC.²²
Apr 2, 2024Sold 842 shares at $243.26 of MADRIGAL PHARMACEUTICALS, INC.²²
Apr 2, 2024Exercised options 10,912 shares at $105.08 of MADRIGAL PHARMACEUTICALS, INC.²²
Apr 1, 2024Sold 274 shares at $266.91 of MADRIGAL PHARMACEUTICALS, INC.²²
Apr 1, 2024Sold 500 shares at $265.49 of MADRIGAL PHARMACEUTICALS, INC.²²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCytokinetics, Board member
2
SEC EDGARMADRIGAL PHARMACEUTICALS, INC., Board member
3
SEC EDGARAcadia Pharmaceuticals, Board member
4
SEC EDGARHalozyme Therapeutics, Board member
5
SEC EDGARBELLICUM PHARMACEUTICALS, INC, Board member
6
SEC EDGARChimerix (United States), Board member
7
SEC EDGARIncyte, Exec. VP & Chief Comm. Officer
8
SEC EDGARHalozyme Therapeutics shares after the filing of Aug 14, 2023
9
SEC EDGARMADRIGAL PHARMACEUTICALS, INC. shares after the filing of Jun 17, 2026
10
SEC EDGARAcadia Pharmaceuticals shares after the filing of May 29, 2026
11
SEC EDGARCytokinetics shares after the filing of Jul 15, 2026
12
SEC EDGARBELLICUM PHARMACEUTICALS, INC shares after the filing of Jan 3, 2023
13
SEC EDGARForm 4 filed May 27, 2026
14
SEC EDGARForm 4 filed Apr 15, 2026
15
SEC EDGARForm 4 filed Jan 20, 2026
16
SEC EDGARForm 4 filed Nov 12, 2025
17
SEC EDGARForm 4 filed Jun 24, 2025
18
SEC EDGARForm 4 filed Jun 2, 2025
19
SEC EDGARForm 4 filed Feb 28, 2025
20
SEC EDGARForm 4 filed Jun 27, 2024
21
SEC EDGARForm 4 filed May 31, 2024
22
SEC EDGARForm 4 filed Apr 3, 2024